All data are based on the daily closing price as of May 1, 2026
l

L&C Bio

290650.KQ
42.72 USD
-4.54
-9.61%

Overview

Last close
42.72 usd
Market cap
1.04B usd
52 week high
81.75 usd
52 week low
10.84 usd
Target price
54.31 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
17.9793
Price/Book Value
8.5748
Enterprise Value
1.19B usd
EV/Revenue
20.5333
EV/EBITDA
12.6876

Key financials

Revenue TTM
58.03M usd
Gross Profit TTM
30.81M usd
EBITDA TTM
7.91M usd
Earnings per Share
N/A usd
Dividend
0.03 usd
Total assets
316.51M usd
Net debt
38.50M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top